NCT04645147 2025-07-17Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV InfectionNational Institutes of Health Clinical Center (CC)Phase 1 Active not recruiting83 enrolled